Theralase(R) Releases Corrected and Restated Press Release f

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

San Francisco , California , United States , Chicago , Illinois , Toronto , Ontario , Canada , Russia , Russian , American , Canadian , Roger Dumoulin White , Arkady Mandel , Company Anti , Clean Technology , Ontario Securities Commission , Technologies Inc , Venture Exchange , American Urology Association , Regulation Services Provider , Toronto Stock Venture Exchange , Company Board Of Directors , Toronto Stock Exchange Venture , Theralase Technologies Inc , International Bladder Cancer Group , Company Photo Dynamic Compounds , Company Annual Meeting On , Development Expenses , Life Sciences , American Society Of Clinical Oncology , Tertiary Objectives , Photo Dynamic Compounds , Financial Statements , Consolidated Statements , Canadian Dollars , Anti Cancer Therapy , Chief Executive Officer , Chief Scientific Officer , Settlement Agreement , Annual Meeting , Diversified Industries , Scientific Advisory Board , Indeterminate Response , Urothelial Cell Carcinoma , Complete Response , Clinical Oncology , Evaluable Patients , Principal Investigator , Study Treatment , American Society , Genito Urinary , Cancer Symposium , Prostate Cancer , Urology Association , Unresponsive Nonmuscle Invasive Bladder Cancer , Developing Drugs , Unresponsive Non Muscle Invasive Bladder Cancer , Carcinoma In Situ , Study Sites , Adverse Events , Study Drug , Study Device , More Information , Chief Financial , Theralase Technologies ,